Northwell Health and Cold Spring Harbor Laboratory have recruited Robert G. Maki, MD, PhD, an internationally-renowned sarcoma cancer physician and researcher, to join the leadership of the Northwell Health Cancer Institute. Based at the Monter Cancer Center in Lake Success, he serves as director of experimental therapeutics of the Don Monti Division of Medical Oncology and Hematology at North Shore University Hospital and Long Island Jewish (LIJ) Medical Center, and director of the Center for New Cancer Therapies at the Northwell Health Cancer Institute.
Dr. Maki is a professor of hematology/oncology at the Hofstra Northwell School of Medicine and professor and member of the National Cancer Institute-designated Cancer Center at Cold Spring Harbor Laboratory (CSHL). He will play a key role in the strategic affiliation between Northwell and CSHL, which was established in 2015 to accelerate cancer research, diagnosis and treatment. Dr. Maki’s position as director includes building a portfolio of clinical research and exploring unique therapeutics for all cancers, which will increase cutting-edge treatment options for patients throughout the healthcare system.
He has extensive experience and expertise in the development of novel therapies to attack molecular targets for the treatment of soft-tissue and bone sarcomas. Additionally, he will oversee the expansion of the basic and translational sarcoma cancer research program in collaboration with CSHL. As part of the affiliation, CSHL and Northwell Health’s academic oncologists and clinicians will be pursuing bench-to-bedside research and clinical trials to improve the outcome of patients with this aggressive cancer using promising new agents.
“We are pleased to welcome Dr. Maki, a highly-esteemed oncologist and researcher, who has made a lifelong commitment to finding a cure for sarcoma, to head our new experimental therapeutics program at the Northwell Health Cancer Institute,” said Lawrence Smith, MD, Northwell Health’s physician-in-chief and dean of the Hofstra Northwell School of Medicine. “Dr. Maki’s new leadership role marks an exciting time in the Cold Spring Harbor Laboratory-Northwell Health strategic collaboration, enabling us to focus our expertise on developing new clinical trials and treatment options more quickly to help patients fighting sarcoma and other complex cancers.”
“We are pleased that Dr. Maki will lead the joint Northwell Health Cancer Institute - Cold Spring Harbor Laboratory initiative to establish a Cancer Clinical Research Center that will greatly facilitate the ability to translate the outstanding basic science at CSHL into the clinic, enabling assessment of the effectiveness of new therapies in patients” said Bruce Stillman, President of CSHL. “Dr. Maki is an outstanding clinician-scientist who will work closely with oncologists at Northwell and scientists at CSHL to advance cancer treatment.”
The CSHL-Northwell Health clinical collaboration distinguishes the health system from other cancer specialty centers for its ability to deliver cancer therapeutics to patients throughout the region, while also meeting the comprehensive medical and surgical needs of those with cancer and at risk of the disease. Every year, Northwell Health treats more than 16,000 patients with cancer, giving patients access to the services of more than 200 physicians in more than 25 sub-specialties.
Dr. Maki, who has 25 years of clinical and research experience, joined Northwell Health from Mount Sinai Medical Center in Manhattan, where he was medical director of the Sarcoma Cancer Program in The Tisch Cancer Institute and also chief of the Pediatric Hematology/Oncology Division. He has published more than 100 articles on sarcoma treatment and basic science research. Dr. Maki treats patients with all types of sarcomas, including connective tissue cancers of bone, cartilage, muscle, fat and other soft tissue.
Previously, Dr. Maki served as co-director of the Adult Sarcoma Program at Memorial Sloan-Kettering Cancer Center. He received his PhD in immunology and molecular biology of sarcomas and MD degree from Weill Cornell Medical College. He completed a residency in internal medicine at the Brigham and Women's Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute, both in Boston, and was on staff at Dana-Farber Dr. Maki is also the Director of Translational Oncology at the Sarcoma Alliance for Research through Collaboration (SARC).
About Northwell Health
Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals and over 500 outpatient practices. We care for more than 1.8 million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees – including 15,000+ nurses and 2,500+ doctors within Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institute. We're training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit Northwell.edu.
Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL has been a National Cancer Institute designated Cancer Center since 1987. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. The Meetings & Courses Program hosts more than 12,000 scientists from around the world each year on its campuses in Long Island and in Suzhou, China. The Laboratory's education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers. For more information, visit www.cshl.edu
Betty Olt/Northwell Health
516-321-6709/ [email protected]
Dagnia Zeidlickis /Cold Spring Harbor Laboratory
516-367-6846/ [email protected]